Literature DB >> 15464891

Amyloid-beta precursor protein processing in neurodegeneration.

Valérie Wilquet1, Bart De Strooper.   

Abstract

The amyloid-beta precursor protein is proteolytically cleaved by secretases, resulting in a series of fragments, including the amyloid-beta peptide of Alzheimer's disease. The amyloid precursor protein, when membrane anchored, could operate as a receptor. After cleavage, the soluble ectodomain exerts a trophic function in the subventricular zone. The amyloid-beta peptide itself has a depressant role in synaptic transmission, with both physiological and pathological implications. During the past two years, much time has been invested in determining the molecular pathways that regulate the processing and the signal transduction of the amyloid precursor protein. However, the absence of consistent and informative phenotypes in different loss of function animal models make elucidating the molecular actions of the amyloid-beta precursor protein an ongoing challenge.

Entities:  

Mesh:

Substances:

Year:  2004        PMID: 15464891     DOI: 10.1016/j.conb.2004.08.001

Source DB:  PubMed          Journal:  Curr Opin Neurobiol        ISSN: 0959-4388            Impact factor:   6.627


  66 in total

Review 1.  Neuronutrition and Alzheimer's disease.

Authors:  Balenahalli N Ramesh; T S Sathyanarayana Rao; Annamalai Prakasam; Kumar Sambamurti; K S Jagannatha Rao
Journal:  J Alzheimers Dis       Date:  2010       Impact factor: 4.472

2.  An alternative interpretation of the amyloid Abeta hypothesis with regard to the pathogenesis of Alzheimer's disease.

Authors:  Vincent T Marchesi
Journal:  Proc Natl Acad Sci U S A       Date:  2005-06-20       Impact factor: 11.205

3.  Alterations of zinc transporter proteins ZnT-1, ZnT-4 and ZnT-6 in preclinical Alzheimer's disease brain.

Authors:  Ganna Lyubartseva; Jennifer L Smith; William R Markesbery; Mark A Lovell
Journal:  Brain Pathol       Date:  2009-04-07       Impact factor: 6.508

4.  A polymorphism in CALHM1 influences Ca2+ homeostasis, Abeta levels, and Alzheimer's disease risk.

Authors:  Ute Dreses-Werringloer; Jean-Charles Lambert; Valérie Vingtdeux; Haitian Zhao; Horia Vais; Adam Siebert; Ankit Jain; Jeremy Koppel; Anne Rovelet-Lecrux; Didier Hannequin; Florence Pasquier; Daniela Galimberti; Elio Scarpini; David Mann; Corinne Lendon; Dominique Campion; Philippe Amouyel; Peter Davies; J Kevin Foskett; Fabien Campagne; Philippe Marambaud
Journal:  Cell       Date:  2008-06-27       Impact factor: 41.582

5.  SOD3 Ameliorates Aβ25-35-Induced Oxidative Damage in SH-SY5Y Cells by Inhibiting the Mitochondrial Pathway.

Authors:  Rong Yang; Li Wei; Qing-Qing Fu; Hua You; Hua-Rong Yu
Journal:  Cell Mol Neurobiol       Date:  2016-06-07       Impact factor: 5.046

6.  Growth arrest-specific 1 binds to and controls the maturation and processing of the amyloid-beta precursor protein.

Authors:  Julien Chapuis; Valérie Vingtdeux; Fabien Campagne; Peter Davies; Philippe Marambaud
Journal:  Hum Mol Genet       Date:  2011-02-28       Impact factor: 6.150

7.  Structure and biochemical analysis of the heparin-induced E1 dimer of the amyloid precursor protein.

Authors:  Sven O Dahms; Sandra Hoefgen; Dirk Roeser; Bernhard Schlott; Karl-Heinz Gührs; Manuel E Than
Journal:  Proc Natl Acad Sci U S A       Date:  2010-03-08       Impact factor: 11.205

Review 8.  A review of the mammalian unfolded protein response.

Authors:  Anirikh Chakrabarti; Aaron W Chen; Jeffrey D Varner
Journal:  Biotechnol Bioeng       Date:  2011-08-09       Impact factor: 4.530

9.  Loss of Hsp110 leads to age-dependent tau hyperphosphorylation and early accumulation of insoluble amyloid beta.

Authors:  Binnur Eroglu; Demetrius Moskophidis; Nahid F Mivechi
Journal:  Mol Cell Biol       Date:  2010-08-02       Impact factor: 4.272

10.  AMP-activated protein kinase signaling activation by resveratrol modulates amyloid-beta peptide metabolism.

Authors:  Valérie Vingtdeux; Luca Giliberto; Haitian Zhao; Pallavi Chandakkar; Qingli Wu; James E Simon; Elsa M Janle; Jessica Lobo; Mario G Ferruzzi; Peter Davies; Philippe Marambaud
Journal:  J Biol Chem       Date:  2010-01-14       Impact factor: 5.157

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.